Connect with us

Business

Johnson & Johnson vaccine hits production snags – POLITICO

The company could seek emergency authorization from FDA this month, but supplies may be thin at first.

Published

on

post featured image
ADVERTISEMENT

A Johnson & Johnson spokesperson declined to confirm the delay, but said the company remains “confident in our ability to meet our 2021 supply commitments.”
“We remain in active discussions with regulators, including on the approval and validation of our manufacturing processes,” the spokesperson said.
“Operation Warp Speed is working with Johnson & Johnson to scale up and maximize manufacturing of the Janssen vaccine,” an HHS spokesperson said. “Making projections at this time is premature.”
Warp…

Click here to view the original article.

Continue Reading
Advertisement

You might also like ...

post featured image
Apple CEO Tim Cook once gave President Trump a $5,999 Mac Pro – CNN
post featured image
Dow Jones Futures: Apple, AMD, Nvidia Lead But Stock Market Rally Warnings Grow Louder; Intel Headlines Earnings Movers Late – Investor’s Business Daily
post featured image
Eli Lilly’s antibody therapy helps prevent Covid-19 in nursing homes, drugmaker says – CNN